UNSPSC 85371700: Diagnoses of reactive arthropathies

This classification denotes the group of activities that yields a diagnosis of Reactive Arthropathies.

Reactive Arthropathies is listed In The World Health Organization's International Statistical Classification of Diseases and Related Health Problems or Icd-10 as a Three Digit Category under code A00 Icd-10 Also Has The Following Reactive Arthropathies Children in its Four-Character Category: M020 or Arthropathy Following Intestinal Bypass; M021 or Postdysenteric Arthropathy; M022 or Postimmunization Arthropathy; M023 or Reiter Disease; M028 or Other Reactive Arthropathies; M029 or Reactive Arthropathy, Unspecified

UNSPSC 85371700 Diagnoses of reactive arthropathies is a Class code whose recent state and local postings show little alignment with the code's nominal clinical scope. The three opportunities identified span diagnostic imaging infrastructure (a PACS system implementation), ultrasound equipment procurement, and phlebotomy services — none of which directly address reactive arthropathy diagnosis. San Mateo Medical Center is procuring an enterprise PACS with EPIC integration to support radiology, cardiology, and dental imaging workflows; Collier County, Florida is single-sourcing ultrasound equipment from EchoNous; and the Albuquerque Police Department is contracting for on-call blood draw services. These acquisitions reflect broader healthcare infrastructure and clinical support needs rather than the specific diagnostic protocols the code nominally describes. The issuing bodies span county health systems, county procurement offices, and municipal police departments — a diverse mix of health-focused and public-safety jurisdictions.

Geographic activity centers on California (San Mateo County), Florida (Collier County), and New Mexico (Albuquerque), with no clear concentration in any single region. The San Mateo Medical Center PACS RFP, posted July 9, 2026 with an August 7, 2026 deadline, is the most substantive recent opportunity, evaluating proposals on a 30-25-20-25 split across project approach, firm qualifications, team qualifications, and price, with a 5–10% local preference available and a nine- to twelve-month implementation window. The mismatch between the code's clinical taxonomy and the actual procurement activity suggests either systematic miscoding by the issuing bodies or a loose UNSPSC mapping that does not serve reliable filtering for vendors in reactive arthropathy diagnostics. Business development professionals should verify whether this code accurately reflects their target market before investing significant pursuit effort.